NCT04915183 2026-03-09
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
11 trialsNCT04767984 2026-01-21
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Northwestern University
Phase 2 Active not recruiting
NCT06553157 2026-01-20
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Minia University
Phase 1/2 Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT02958852 2025-09-10
ABC-SE
Lund University Hospital
Phase 2 Completed
NCT02603328 2025-08-22
AT CASH EPOC
University of Chicago
Phase 1/2 Completed
NCT04379999 2025-08-07
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Fox Chase Cancer Center
Phase EARLY_PHASE1 Completed
NCT03819101 2025-06-26
PEACE-4
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Recruiting
NCT02943590 2025-05-15
STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)
Massachusetts General Hospital
Phase 2 Completed
NCT04789057 2025-05-08
Captain
Medical University of Bialystok
Phase 4 Recruiting
NCT06102863 2025-04-29
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting